Falsely low vancomycin results using the Abbott TDx

Annals of Clinical Biochemistry

Volumn 37, Issue 3, 2000, Pages 411-413

  Wood, F L ^a   Earl, J W ^a   Nath, C ^a   Coakley, J C ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ACCURACY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; FLUORESCENCE POLARIZATION; HEARING LOSS; HUMAN; INTERMETHOD COMPARISON; NEPHROTOXICITY; PRIORITY JOURNAL;

EID: 0034049235     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563001899366     Document Type: Article

References (5)

1. Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996
2. Leal T, Dupret P, Hassoun A, Wallemacq PE. Topical application of eosin to burns produces interference in measurement of serum vancomycin by fluorescence polarization immunoassay. Clin Chem 1997; 43: 1238-9
3. Morse GD, Nairn DK, Bertino JS, Walshe JJ. Overestimation of vancomycin concentrations utilizing fluorescence polarization immunoassay in patients on peritoneal dialysis. Ther Drug Monit 1987; 9: 212-5
4. Paap CM, Sharpe GL. Overestimation of serum vancomycin concentrations using a fluorescence polarization immunoassay (Tdx) in preterm neonates. Dev Pharmacol Ther 1993; 20: 174-9
5. Azzazy HME, Chou PP, Tsushima JH, Troxil S, Gordon M, Avers RJ, et al. Abbott AxSYM vancomycin II assay: multicenter evaluation and interference studies. Ther Drug Monit 1998; 20: 202-8